1. Correlation between mucin biology and tumor heterogeneity in lung cancer
   Menglin Xu et al, 2017, Seminars in Cell & Developmental Biology CrossRef
2. Chaperonin containing TCP1 subunit 5 is a tumor associated antigen of non-small cell lung cancer
   Hongjun Gao et al, 2017, Oncotarget CrossRef
3. Antibodies against aberrant glycans as cancer biomarkers
   Anna Blsakova et al, 2019, Expert Review of Molecular Diagnostics CrossRef
4. Parallel Glyco-SPOT Synthesis of Glycopeptide Libraries
   Akul Y. Mehta et al, 2020, Cell Chemical Biology CrossRef
5. Epitopes of MUC1 Tandem Repeats in Cancer as Revealed by Antibody Crystallography: Toward Glycopeptide Signature-Guided Therapy
   Dapeng Zhou et al, 2018, Molecules CrossRef
6. An antibody‐drug conjugate targeting a GSTA glycosite‐signature epitope of MUC1 expressed by non‐small cell lung cancer
   Deng Pan et al, 2020, Cancer Medicine CrossRef
7. Immunogenicity of Del19 EGFR mutations in Chinese patients affected by lung adenocarcinoma
   Deng Pan et al, 2019, BMC Immunology CrossRef
8. A novel Tn antigen epitope‑recognizing antibody for MUC1 predicts clinical outcome in patients with primary lung adenocarcinoma
   Tatsuya Kato et al, 2021, Oncology Letters CrossRef
9. Mining the Immunopeptidome for Antigenic Peptides in Cancer
   Ricardo A. León-Letelier et al, 2022, Cancers CrossRef
10. Unraveling O-Glycan Diversity of Mucins: Insights from SmE Mucinase and Ultraviolet Photodissociation Mass Spectrometry
    Amanda Helms et al, 2024, Analytical Chemistry CrossRef
11. Separation and detection of minimal length glycopeptide neoantigen epitopes centering the GSTA region of MUC1 by liquid chromatography/mass spectrometry
    Dapeng Zhou et al, 2020, Rapid Communications in Mass Spectrometry CrossRef